# Investigator Initiated Phase 1 Study of TBI-1201

> **NCT02096614** · PHASE1 · COMPLETED · sponsor: **Mie University** · enrollment: 18 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** TBI-1201
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT02096614
- **Lead sponsor:** Mie University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02096614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02096614, "Investigator Initiated Phase 1 Study of TBI-1201". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02096614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*